Financials

  • Market Capitalization 3.87 B
  • Employee 145
  • Founded 2015
  • CEO N/A
  • Website www.ideayabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00CTZ4D83
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-27.01
ratio cours/chiffre d'affaires
13.99

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1518
TNGX
Tango Therapeutics, Inc. - Common Stock
23.34 USD-7.67%-1.10%-13.01%+253.10%3.94 B USD
1532
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
34.74 USD-6.56%-10.09%+71.22%+277.61%3.87 B USD
1541
DNLI
Denali Therapeutics Inc. - Common Stock
24.00 USD-2.72%-3.54%+5.03%+48.42%3.84 B USD
1544
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.29 USD-0.79%-1.48%+10.69%+78.92%3.82 B USD

Nouvelles